Phase 4 Type 2 Diabetes Trial, Recruiting (NCT06461377)

Phase 4 Type 2 Diabetes Trial, Recruiting NCT06461377 Sponsor: The First Affiliated Hospital with Nanjing Medical University Condition: Type 2 Diabetes

Printed from Voxsanity (voxsanity.com.au) — NCT06461377 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Type 2 Diabetes

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults between 18 and 70 years of age
People who have been diagnosed with type 2 diabetes, according to recognised diagnostic guidelines
People who have signed the required consent forms agreeing to take part in the study
People who are classified as overweight or obese

Who may not be able to join:

People under 18 years of age
Women who are pregnant or currently breastfeeding
People who have pancreatitis, either as a recent (acute) or long-term (chronic) condition
People who have recently experienced a serious sudden complication related to their diabetes (confirm with trial site)
People who have an irregular heartbeat, or who are taking medications that affect heart rate
People who have a thyroid condition
People who have serious problems with major organs such as the kidneys, liver, or heart (confirm with trial site)
People who have not agreed to or have declined to sign the informed consent form

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 19 July 2026

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Principal Investigator: jianbo Li, MD/PhD, First Affiliated Hospital，Nanjing Medical University，China

Phone: 13951750648

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06461377

Sponsor: The First Affiliated Hospital with Nanjing Medical University

Phase: Phase 4

Status: Recruiting

Condition: Type 2 Diabetes

Trial contact: 13951750648

More information: https://clinicaltrials.gov/study/NCT06461377

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults between 18 and 70 years of age
People who have been diagnosed with type 2 diabetes, according to recognised diagnostic guidelines
People who have signed the required consent forms agreeing to take part in the study
People who are classified as overweight or obese

Who may not be able to join:

People under 18 years of age
Women who are pregnant or currently breastfeeding
People who have pancreatitis, either as a recent (acute) or long-term (chronic) condition
People who have recently experienced a serious sudden complication related to their diabetes (confirm with trial site)
People who have an irregular heartbeat, or who are taking medications that affect heart rate
People who have a thyroid condition
People who have serious problems with major organs such as the kidneys, liver, or heart (confirm with trial site)
People who have not agreed to or have declined to sign the informed consent form

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 19 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 4

Sponsor

The First Affiliated Hospital with Nanjing Medical University

Registry

ClinicalTrials.gov

Start date

13 June 2024

Est. completion

31 December 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

heart rate variability（HRV）

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov